Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
JMIR AI|June 14, 2024
Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning-Based Natural Language ProcessingKyeryoung Lee, Zongzhi Liu, Urmila Chandran, et al.British Journal of Haematology|November 9, 2022
Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasmsAndrew J Shih, Tomi Jun, Andrew D Skol, et al.Journal for Immunotherapy of Cancer|September 2, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international studyPetros Fessas, Ahmed Kaseb, Yinghong Wang, et al.Therapeutic Advances in Medical Oncology|May 17, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinomaTomi Jun, Umut Ozbek, Sirish Dharmapuri, et al.Cancers|July 16, 2020
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI GradeDavid J Pinato, Takahiro Kaneko, Anwaar Saeed, et al.Journal for Immunotherapy of Cancer|October 8, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapyDavid J Pinato, Ahmed Kaseb, Yinghong Wang, et al.Hepatology Communications|April 28, 2022
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCCRohini Sharma, Anjana Pillai, Thomas Urban Marron, et al.Liver Cancer|December 24, 2021
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular CarcinomaPetros Fessas, Muntaha Naeem, Matthias Pinter, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 28, 2022
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational studyThomas Talbot, Antonio D'Alessio, Matthias Pinter, et al.Lung Cancer (Amsterdam, Netherlands)|August 30, 2021
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes studySheena Bhalla, Ziad Bakouny, Andrew L Schmidt, et al.Pageof 5